Home/Publication/Orchid Asia in Cancer Treatment Play
Orchid Asia in Cancer Treatment Play 

23 Sep 2025

US$ 20.00

Orchid Asia Group Management Ltd has participated in the series B3 fundraising round of Shanghai Affinity...

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly for the week ending 26 Sep 2025...

Chiratae Ventures has raised US$150 m for the second closing of its Chiratae Ventures India Fund V...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.